Dr. Ali Khodabandeh, MD

Dr. Khodabandeh practices at Mass Lung & Allergy in Leominster, Massachusetts.

Dr. Khodabandeh's NPI, 1841485695, was assigned on September 13, 2007. Dr. Khodabandeh holds Massachusetts license 242004.

Dr. Khodabandeh's primary practice is Mass Lung & Allergy, at 100 Hospital Rd, Leominster, MA 01453. The practice phone is (978) 466-2692.

Dr. Khodabandeh's primary practice is Mass Lung & Allergy in Leominster, Massachusetts. Dr. Khodabandeh is also affiliated with UMass Memorial Health - HealthAlliance-Clinton Hospital. The medical group on file is Mass Lung & Allergy. Dmand AI also links Dr. Khodabandeh to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Khodabandeh's employer is on file too: an imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khodabandeh practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Khodabandeh's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Khodabandeh is licensed in Massachusetts.

CMS data shows 2,210 Medicare services from Dr. Khodabandeh across 14 procedure codes in 2024, for 617 Medicare patients. Medicare paid $240,677 for them.

CMS counts 617 Medicare patients who saw Dr. Khodabandeh in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khodabandeh's median patient age at 68, with 52% women.

In 2024, Dr. Khodabandeh wrote 1,983 Medicare Part D claims for 329 patients. 29% of them were for generic drugs. CMS names the drug for 1,896 of them, across 23 drugs with 11 or more claims each, at $735,379 in total drug cost. In 2023, CMS named 1,629 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khodabandeh for performance year 2024, reported through an alternative payment model (APM). Dr. Khodabandeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khodabandeh as offering telehealth.

Dmand AI links 3 papers to Dr. Khodabandeh in 2015. 2015 was the busiest year, with 2. The most frequent topics are Hospital Mortality, Intensive Care Units and Massachusetts. Dr. Khodabandeh's most frequent co-authors are Imad J. Bahhady, MD, Irwin A. Buchwald, MD and Nicholas S. Hill, MD.

CMS Open Payments shows 541 general payments to Dr. Khodabandeh from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $3,487.